-
European Commission Grants Approval of OGSIVEO® (nirogacestat) for the Treatment of Adults with Desmoid Tumors
18 Aug 2025 13:23 GMT
STAMFORD, Conn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc., a healthcare company of Merck, announced today that the European Commission (EC) granted marketing authorization for OGSIVEO® (nirogacestat), an oral gamma secretase …
-
European Commission Grants Approval of OGSIVEO® (nirogacestat) for the Treatment of Adults with Desmoid Tumors
18 Aug 2025 13:10 GMT
STAMFORD, Conn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany, announced today that the European Commission (EC) granted marketing authorization for OGSIVEO® (nirogacestat), an …
-
European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
18 Jul 2025 15:30 GMT
STAMFORD, Conn., July 18, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany, announced today that the European Commission (EC) granted conditional marketing authorization for EZMEKLY® ( …
-
European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
18 Jul 2025 15:30 GMT
STAMFORD, Conn., July 18, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc., a healthcare company of Merck, announced today that the European Commission (EC) granted conditional marketing authorization for EZMEKLY® (mirdametinib) for the treatment of …
-
MilliporeSigma Announces Neoclease as Winner of 2025 North American Advance Biotech Grant
18 Jun 2025 12:12 GMT
… North American Advance Biotech Grant. The Boston-based biotech … requirements.
The Advance Biotech Grant Program, launched in 2014, … companies worldwide have received grants and technical support across … in life science, EMD Serono in healthcare and EMD …
-
Merck Announces Emerging Biotech Grant Program Winners
01 Nov 2024 07:30 GMT
… its Emerging Biotech (EB) Grant Program in Asia Pacific. The … discovery to manufacturing with our grant program," said Chua … 47;startup-programs#our-grant-programs
Other Merck grants at group level … in life science, EMD Serono in healthcare, and EMD …
-
MilliporeSigma Announces Siren Biotechnology as Winner of its North American Advance Biotech Grant
04 Jun 2024 12:27 GMT
… , Germany. “Our Advance Biotech Grant Program provides the products, technologies … business’s Advance Biotech Grant Program has awarded technologies … set to award additional grants in APAC in July … in life science, EMD Serono in healthcare and EMD Electronics …
-
FDA Grants Full Approval to Tepmetko for Metastatic NSCLC Subtype
16 Feb 2024 19:32 GMT
EMD Serono, Merck KGaA’s biopharmaceutical … lung-cancer
2. FDA grants accelerated approval to tepotinib … approved-drugs/fda-grants-accelerated-approval-tepotinib-metastatic-non … . Tepmetko. Prescribing information. EMD Serono; 2024. Accessed February 16, …
-
FDA grants breakthrough therapy designation to opioid with ‘overdose protection’
29 Jan 2024 13:19 GMT
January 29, 2024
2 min read
Add topic to email alerts
Subscribe
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Back to Healio
Key takeaways:
PF614-MAR helps …
-
BIORCHESTRA Wins Grand Prize in 2023 Merck Advance Biotech Grant Program
18 Jul 2023 23:40 GMT
… the 2023 Merck Advance Biotech Grant Program.
Since 2014, Merck… #39;s Advance Biotech Grant program has recognized innovative biotechnology … in life science, EMD Serono in healthcare, and EMD … -2023-merck-advance-biotech-grant-program-301878509.html
SOURCE …